4-Phenyl substituted tetrahydroisoquinolines and therapeutic use thereof
US7419985B2 · kind B2 · utility
15Cited by
16References
38Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 21, 2005 |
| Grant date | Sep 2, 2008 |
| Priority date | — |
| Expiry date | Sep 21, 2025 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D495/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds are provided that, by way of their selective neurotransmitter binding useful for the treatment of various neurological and psychological disorders, e.g., ADHD. Such compounds are 4-phenyl substituted tetrahydroisoquinolines having the Formula IA, IB, IIA, IIB, IIIA or IIIC as set forth herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.